AI Panic Spreads Across Industries: The Collapse of Health Insurance, Retail Dip-Buying, and the Market's Persistent Question of AI's 'True Value'
Legendary investor Steve Eisman, known for The Big Short, released his weekly report for the week ending February 13, 2026. As fear of AI spreads beyond specific sectors to the entire market and the structural collapse of health insurance intensifies, individual investors continue to 'buy the dip.' What happened in the market last week, and what does it mean? We decode it from Eisman's perspective.
1. Individual investors keep buying the dip—but how long will that work?
The market fell about 2% by Thursday last week, but recovered almost all of that loss on Friday alone. The main driver of this price action is 'buying the dip' by individual investors.
Eisman puts it bluntly: 'Buying the dip will continue to work. Until the day it doesn't. That turning point will come when a full-scale, broad-based recession arrives, going beyond the localized downturn currently hitting the bottom of the K-shaped economy.'
For now, the market is resilient, but that support is not rock-solid. Due to the explosion in AI-related capital expenditure (CAPEX), even hyperscalers like Google are expected to have nearly zero cash flow this year. Whether the hundreds of billions of dollars being poured into AI will truly generate returns—until that answer is clear, market anxiety will persist.
2. The reality for US consumers: A K-shaped economy with deepening polarization
Consumer data continues to send mixed signals.
December retail sales remained flat, against market expectations of a 0.4% month-over-month increase. Following this weak figure, US Treasury yields fell, providing a tailwind for homebuilder stocks. However, the next day, when the January employment report was released, non-farm payrolls exceeded expectations with an increase of 130,000. This time, Treasuries were sold off.
Eisman's summary is clear: 'Low-income consumers are definitely suffering. However, high-income earners are supporting the overall data, and at least for now, that is working.'
Furthermore, refund checks associated with the Trump administration's 'Big Beautiful Bill' tax cut legislation are expected to be issued soon, which may temporarily support consumer sentiment. However, Eisman remains cautious, noting that there is a risk that the effect 'could fade in the second half of this year.'
2-1. The Obesity Drug War: Novo Nordisk vs. HIMS
A new legal battle has begun in the pharmaceutical sector. Novo Nordisk has sued Hims & Hers Health (ticker: HIMS). They have taken legal action, alleging that HIMS is selling copycat injectable versions of Wegovy. On this news, Novo Nordisk rose 3% on Monday, while HIMS fell 16%.
3. AI panic spreads across industries—a week where the target changed every day
The most notable feature of this week was that fear of AI hit a different sector every day.
3-1. Monday: Insurance brokers plummet
Following reports that OpenAI had approved an AI app for personal insurance, insurance brokers recorded drops of up to 10% in a single day. Eisman questions this reaction: 'What insurance brokers provide are complex services for corporations. OpenAI's app is only for personal insurance. But in this environment, investors sell first and think later—or never think at all.'
3-2. Tuesday: Retail brokerage and asset management sold off
Fintech platform Altruist announced an AI-powered tax-saving tool. On that news alone, Raymond James fell 9%, LPL Financial fell 8%, and Charles Schwab fell 7%.
3-3. Wednesday/Thursday: Commercial real estate and logistics targeted
On Wednesday, CBRE and JLL each fell 12%. On Thursday, logistics stocks, led by CH Robinson, recorded drops of over 15% due to concerns about AI replacement.
Eisman's comment is laced with irony. "Every day is an AI adventure."
4. The Structural Collapse of Health Insurance—The Molina Disaster Highlights Industry-Wide Issues
The crisis in the health insurance industry, exemplified by UnitedHealth, was brought into sharp focus once again by Molina's earnings.
Molina's fourth-quarter earnings missed on all counts. EPS showed a loss of $2.75 (market expected a profit), and the Medical Loss Ratio (MLR) exceeded expectations for both Medicare and Medicaid.
The performance trajectory is dire. 2025 EPS is projected at $11, a 51% decline from 2024. A further 13% decline is expected in 2026. Eisman states bluntly, "The PE multiples for health insurance stocks have collapsed. But the business models have collapsed as well. It will take these companies much longer to fix their problems."
Molina stock is down 27% year-to-date and over 50% in the last 12 months.
5. Individual Stock Highlights—A Season of Contrasting Earnings
5-1. S&P Global—The Aftermath of Software Fear
S&P Global's earnings missed EPS by only 3 cents, but the stock plunged 10% because its 2026 revenue guidance fell slightly below consensus. On the same day, rating rival Moody's also fell 7%. Eisman's view is clear: "This weak guidance has nothing to do with AI. But investors are panicking about software and are looking for an excuse to sell."
5-2. Winners and Losers in AI Infrastructure—Cisco and Arista
Cisco beat expectations on both EPS and revenue, with a revenue growth rate of 10%—a "heroic" figure for the company—but fell 7% in after-hours trading because its next-quarter guidance missed market expectations. Meanwhile, its biggest rival, Arista, beat on both EPS and revenue and provided strong Q1 guidance, causing its stock to rise in after-hours trading. It is a classic example of how the strength of guidance dictates stock performance.
5-3. Robinhood and Coinbase—Direct Hits from the Crypto Downturn
Robinhood missed on all metrics: revenue, EPS, and net new assets. The stock, already down 24% year-to-date, fell another 9%. Its P/E ratio is over 30x, making it look significantly more expensive than competitor Schwab's 17x. Coinbase saw Q4 revenue fall 22% and missed on EPS. It is down 38% year-to-date. "As long as crypto prices keep falling, the stocks of both companies will keep falling," says Eisman.
6. Mailbag: How to Measure Portfolio Risk and Charter vs. PayPal
6-1. Risk Management Measured by Beta
In response to a reader's question about portfolio management, Eisman introduced a simple and practical method: analysis using Beta.
Beta is an indicator that shows how much an individual stock moves when the market moves 1%, using the S&P 500 (Beta = 1.0) as a benchmark. Eisman illustrated this with an equally weighted 20% portfolio of five stocks (Goldman Sachs, Nvidia, Google, Netflix, and Eli Lilly). Since Nvidia's beta is 1.84, even a 20% weight carries a risk equivalent to 37% after beta adjustment. The beta-adjusted exposure of this entire five-stock portfolio is 121%. "Even if you think you are 100% invested, you may actually be taking on 121% risk"—Eisman emphasizes that this realization is crucial.
6-2. Why Charter is not PayPal
Question from reader Dez: "Charter and PayPal have similar structures—low growth, high cash generation, and shareholder returns—so why is Charter a buy and PayPal not?"
Eisman's answer is clear. Venmo will not be the savior. Of PayPal's $35 billion in 2025 revenue, the contribution from Venmo is only $1.7 billion (about 5%). And, the fundamental problem is the existence of clearly superior competitors like Apple Pay and Google Pay. "PayPal will continue to lose market share. There is no clear fix in sight, and fixing it will require significant investment."
On the other hand, Charter has completed large-scale system updates and possesses the strength of bundled sales. Eisman's prediction is that 'Charter will turn from revenue decline to slight growth, while PayPal faces further risks of deterioration.' He concluded by saying, 'If I were the CEO of PayPal, I would explore a sale to a stronger buyer.'
Conclusion—An Era Where the 'True Value of AI' Is Questioned
What Eisman consistently demonstrated in this week's report is the structure of a current market swaying between expectations for AI benefits and uncertainty. Will the hundreds of billions of dollars invested in AI actually generate returns? The market has yet to find an answer to that question.
While retail investors buying the dip are supporting the market, panic selling across sectors is repeated daily. How long will this imbalance last? While avoiding a definitive statement, Eisman continues to quietly issue a warning: 'When a full-scale recession arrives, the situation will change completely.'
